Codexis
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
200 Penobscot Dr, Redwood City, Californ...Phone Number
(650) 421-8100Website
www.codexis.comRevenue
$78.1 MillionStock Symbol
CDXSIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Codexis
Codexis, Inc. is a leading enzyme engineering company headquartered in Redwood City, California, incorporated in 2002 and publicly traded on the NASDAQ under the ticker symbol CDXS. The company leverages its proprietary CodeEvolver protein engineering technology platform to discover, develop, and enhance novel, high-performance enzymes and other classes of proteins for use in therapeutics manufacturing, molecular diagnostics, and pharmaceutical applications. Codexis enzymes are designed to improve manufacturing yields, reduce energy usage and waste, and increase efficiency in the production of small molecule pharmaceuticals and nucleic acid-based medicines. The company is actively developing its ECO Synthesis platform to enable scalable, enzymatic manufacturing of RNAi therapeutics. Codexis serves pharmaceutical, biotherapeutics, food and beverage, and fine chemical industries, and has received the Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection AgenRead more
Codexis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Codexis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Codexis has new funding data
Click to see if Codexis had a recent Job posting/layoffs
Check if Codexis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Codexis launches new products
Codexis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Codexis recently announced quarterly report
Check out if Codexis is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Codexis
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Codexis
Compare insights from companies similar to Codexis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Codexis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Codexis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Codexis.
Codexis financials insights
Gather financial insights about Codexis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series D
$37M
2010
Stock Offering
$78M
2019
Stock Offering
$5M
2024
Debt
$40M
Codexis Tech Stack
A closer look at the technologies used by Codexis
See more technologies
Most Recent Scoops
Person-Based
Events, Manufacturing Operations
Person-Based
Earnings, Financial Reporting, Finance
Open Position
Hiring Plans
Codexis has more open roles in Operations than it has had at any time in the past 12 months. Technologies mentioned include: Remote.
Hiring Plans
Open Position
Codexis News & Media
Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript
Codexis, Inc. (CDXS) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDTCompany ParticipantsGeorgia Erbez - CFO & Chief Business OfficerAlison MooreBritton...Codexis Reports First Quarter 2026 Financial Results
Reports revenue of $15.2 million for the first quarter, company reiterates full-year financial guidanceCodexis to share RNA manufacturing advances at TIDES USA
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, will present new data on ECO Synthesis® Manufacturing Platform and provide an update on regulatory engagement for its enzymatic platform at TIDES USA, held May 11–14 at the Hynes Convention Center in Boston.Codexis to Report First Quarter 2026 Financial Results on May 7
REDWOOD CITY, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results for the first quarter of 2026 on Thursday, May 7, 2026, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company’s financial results and provide a
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Codexis
Sign Up For FreeTo access detailed company insights
Codexis, Inc. is a leading enzyme engineering company headquartered in Redwood City, California, incorporated in 2002 and publicly traded on the NASDAQ under the ticker symbol CDXS. The company leverages its proprietary CodeEvolver protein engineering technology platform to discover, develop, and enhance novel, high-performance enzymes and other cl... Read More
